Blockade of EGFR improves responsiveness to PD-1 blockade in EGFR-mutated non-small cell lung cancer.
Sugiyama E, Togashi Y, Takeuchi Y, Shinya S, Tada Y, Kataoka K, Tane K, Sato E, Ishii G, Goto K, Shintani Y, Okumura M, Tsuboi M, Nishikawa H.
Sugiyama E, et al. Among authors: ishii g.
Sci Immunol. 2020 Jan 31;5(43):eaav3937. doi: 10.1126/sciimmunol.aav3937.
Sci Immunol. 2020.
PMID: 32005679